Filter posts

“Diverse Candidates Can Win If They Can Get the Interview.”

Diversity is gaining more attention among biotech investors and companies alike. At entry level, 50% …

The Vital Role of Patient Advocacy in Charting the Future of Medicine

For many of us, it is not difficult to remember a time where the role …

Expanded Access – It Continues to Make Headlines

The recent Senate passage of S. 204, the Trickett Wendler, Frank Mongiello, and Jordan McLinn …

The Benefits of Immunization

In today’s Philadelphia Inquirer, BIO President & CEO Jim Greenwood authored an op-ed for National …

Former British PM Describes How Personal Tragedy Inspired Genomics Project for Rare Disease Researc...

At the 2017 BIO International Convention last month in San Diego, former British Prime Minister …

To Compete, Renewables Must Perform

Biomaterials have the potential to reduce greenhouse gas emissions and provide long-term renewable solutions. But …

Biotech is the Future of Agriculture

My name is Brian Glenn and I’m the new food and ag intern for BIO …

Making Sense and Cents Out of Pharma Strategic Venture Investing

For most large pharmaceutical companies, strategic venture arms are no longer a “nice to have,” …

Unleashing CAR-T Therapies on Solid Tumors: Are We There Yet?

Chimeric antigen receptor (CAR) T cell therapies have shown dramatic results against certain blood cancers …

Start-Up CEO: Making the Choices to Develop a Novel Medicine

The choices surrounding research investment and drug development are daunting for even the most experienced …